High risk of autoimmune diseases after COVID-19

The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset autoimmune diseases.

Automated summary

The full understanding of post-COVID-19 autoimmune diseases and their prevalence is limited. However, two large-scale studies have found a significant increase in the risk of developing various new-onset autoimmune diseases linked to SARS-CoV-2 infection.